Utah Medical Products, Inc. (UTMD)

♥ 530 Thanks from members

Utah Medical Products (UTMD) faces top-line revenue headwinds and lower EPS for Q2 and 1H 2026 driven by major customer attrition and slower biopharma OEM sales, though profitability, cash generation, and robust margins remain intact.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →

Other Nasdaq Tickers

NASDAQ

Microchip Technology Incorporated (MCHP)

NASDAQ

Direxion Daily AAPL Bear 1X ETF (AAPD)

NASDAQ

Ascentage Pharma Group International - American Depository Shares (AAPG)

NASDAQ

Direxion Daily AAPL Bull 2X ETF (AAPU)

NASDAQ

Alpha Blue Capital US Small-Mid Cap Dynamic ETF (ABCS)

NASDAQ

AbCellera Biologics Inc. - Common Shares (ABCL)

Entity & Market Metadata

Sector: Healthcare Industry: Medical Devices Founder: Kevin L. Cornwell Leadership: Kevin L. Cornwell (CEO) Leadership: Bryan K. Lord (CFO) Holder: Kevin L. Cornwell Holder: Dimensional Fund Advisors LP Holder: Vanguard Group Inc. Blood Pressure Monitoring Systems Neonatal Care Devices Obstetrical and Gynecological Devices #UTMD stock #Utah Medical Products #womens health devices #NASDAQ UTMD #medical equipment